Chemical Information
Antiviral agent ID	DrugRepV_1892
Antiviral agent name	Seliciclib
IUPAC Name	(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol
SMILES (canonical)	CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C
SMILES (isomeric)	CC[C@H](CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C
Molecular Formula	C19H26N6O
Molecular Weight (g/mol)	354.458
InChl	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1
Structural Information
Clinical Information
Category	Anticancer
Primary Indication (Clinical trial phases)	Investigational
Biological Information
Primary Indication (Disease Category)	Non Infectious Disease
Primary Indication (Disease)	Breast cancer | Lung cancer | Lymphoma | Multiple myeloma | Leukemia
Secondary Indication	Zika virus (ZIKV) NA FSS13026
Secondary Indication (Approaches)	Experimental
Secondary Indication (Methods)	In-vitro
Secondary Indication (Model system) [cell lines/ animal models]	SNB-19 glioblastoma
Secondary Indication (Mode of viral infection)	Adsorption
Secondary Indication (Viral titer)	1 MOI
Secondary Indication (Mode of drug delivery)	Culture
Secondary Indication (Time of drug delivery)	Pre infection (1 hour)
Secondary Indication (Duration of drug delivery)	24 hours
Secondary Indication (Drug concentration)	0.024 μM
Secondary Indication (Change)	Decrease
Secondary Indication (Type of Inhibition)	IC50 [ 50 % ]
Reference	Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X, Tcw J, Kouznetsova J, Ogden SC, Hammack C, Jacob F,.Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.Nat Med. 2016 Oct;22(10):1101-1107. doi: 10.1038/nm.4184. Epub 2016 Aug 29. PMID:27571349
Comment	The identified compounds that either inhibit ZIKV infection or suppress infection-induced caspase-3 activity in different neural cells